Personas / Equipo Humano

Albert Català Temprano

Buscador de publicaciones

Publicaciones

  • Sevilla J, Navarro S, Rio P, Sánchez-Domínguez R, Zubicaray J, Gálvez E, Merino E, Sebastián E, Azqueta C, Casado JA, Segovia JC, Alberquilla O, Bogliolo M, Román-Rodríguez FJ, Giménez Y, Larcher L, Salgado R, Pujol RM, Hladun R, Castillo A, Soulier J, Querol S, Fernández J, Schwartz J, García de Andoín N, López R, Català-Temprano A, Surralles J, Díaz-de-Heredia C and Bueren JA.

    Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes.

    Molecular Therapy-Methods & Clinical Development . 22: 66-75. Nº de citas: 12

    [doi:10.1016/j.omtm.2021.06.001]

  • Trifunov S, Paredes-Fuentes AJ, Badosa-Gallego MC, Codina-Bergadà A, Montoya C, Ruiz-Pesini E, Jou-Munoz C, Garrabou G, Grau-Junyent JM, Yubero-Siles D, Montero-Sanchez R, Muchart-Lopez J, Ortigoza-Escobar JD, O'Callaghan-Gordo M, Nascimento-Osorio A, Català-Temprano A, Garcia-Cazorla A, Jimenez-Mallebrera C and Artuch-Iriberri R.

    Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases

    CLINICAL CHEMISTRY . 67(8): 1113-1121. Nº de citas: 11

    [doi:10.1093/clinchem/hvab091]

  • Ramírez MJ, Pujol R, Trujillo-Quintero JP, Minguillón J, Bogliolo M, Río P, Navarro S, Casado JA, Badell I, Carrasco E, Balmaña J, Català-Temprano A, Sevilla J, Beléndez C, Argilés B, López M, de Heredia CD, Rao G, Nicoletti E, Schwartz JD, Bueren JA and Surrallés J.

    Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.

    AMERICAN JOURNAL OF HEMATOLOGY . 96(8): 989-999. Nº de citas: 14

    [doi:10.1002/ajh.26234]

  • Navarro, S, Sevilla, J, Rio, P, Sanchez, R, Zubicaray, J, Galvez, E, Merino, E, Sebastian, E, Azqueta, C, Casado, JA, Segovia, JC, Alberquilla, O, Bogliolo, M, Roman-Rodriguez, FJ, Gimenez, Y, Larcher, L, Salgado, R, Pujol, RM, Haldun, R, Castillo, A, Soulier, J, Querol, S, Fernandez, J, Shcwartz, J, de Andoin, NG, Lopez, R, Català-Temprano A, Surralles, J, de Heredia, CD and Bueren, JA.

    Hematopoietic Stem Cell Collection for the Gene Therapy of Fanconi Anemia Patients

    MOLECULAR THERAPY . 29(4): 342-342.

  • Gálvez E, Vallespín E, Arias-Salgado EG, Sánchez-Valdepeñas C, Giménez Y, Navarro S, Río P, Bogliolo M, Pujol R, Peiró M, Nevado J, Zubicaray J, Sebastián E, Català-Temprano A, Beléndez C, Díaz de Heredia C, Galera A, Badell I, Madero L, Perona R, Sastre L, Surrallés J, Bueren J, Lapunzina P and Sevilla J.

    Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes.

    hemasphere . 5(4): . Nº de citas: 12

    [doi:10.1097/HS9.0000000000000539]

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives-Solà S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

    Frontiers in pediatrics . 8: 614521-614521. Nº de citas: 5

    [doi:10.3389/fped.2020.614521]

  • Ortíz-Maldonado V, Rives-Solà S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballero-Baños M, Baumann T, Jordi Cid Colom, Garcia-Rey E, Llanos C, Torrebadell-Burriel M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català-Temprano A, Faura A, González EA, Español-Rego M, Klein-González N, Alsina L, Castro P, Jordán-García I, Fernández S, Ramos F, Suñé G, Perpiñá U, Canals JM, Lozano M, Trias E, Scalise A, Varea S, Sáez-Peñataro J, Torres F, Calvo G, Esteve J, Urbano-Ispizua Á, Juan-Otero M and Delgado J.

    CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies

    MOLECULAR THERAPY . 29(2): 636-644. Nº de citas: 99

    [doi:10.1016/j.ymthe.2020.09.027]

  • Deyà-Martinez A, Alonso-Saladrigues A, García, AP, Faura, A, Torrebadell-Burriel M, Vlagea, A, Català-Temprano A, Esteve-Solé A, Juan-Otero M, Rives-Solà S and Alsina L.

    Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

    BONE MARROW TRANSPLANTATION . 56(2): 376-386. Nº de citas: 13

    [doi:10.1038/s41409-020-01027-6]

  • Kozyra EJ, Pastor VB, Lefkopoulos S, Sahoo SS, Busch H, Voss RK, Erlacher M, Lebrecht D, Szvetnik EA, Hirabayashi S, Pasauliene R, Pedace L, Tartaglia M, Klemann C, Metzger P, Boerries M, Català-Temprano A, Hasle H, de Haas V, Kállay K, Masetti R, De Moerloose B, Dworzak M, Schmugge M, Smith O, Starý J, Mejstrikova E, Ussowicz M, Morris E, Singh P, Collin M, Derecka M, Göhring G, Flotho C, Strahm B, Locatelli F, Niemeyer CM, Trompouki E, Wlodarski MW and European Working Group of MDS in Childhood (EWOG-MDS).

    Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

    Leukemia . 34(10): 2673-2687. Nº de citas: 34

    [doi:10.1038/s41375-020-0899-5]

  • Català-Temprano A, Ali SS, Cuvelier GDE, Steele M, Klaassen RJ, Fernandez CV, Pastore YD, Abish S, Rayar M, Jardine L, Breakey VR, Brossard J, Sinha R, Silva M, Goodyear L, Lipton JH, Michon B, Corriveau-Bourque C, Sung L, Lauhasurayotin S, Zlateska B, Cada M and Dror Y.

    Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.

    BRITISH JOURNAL OF HAEMATOLOGY . 189(5): 976-981. Nº de citas: 9

    [doi:10.1111/bjh.16445]